CCL3 and breast carcinoma: Elbaz et al. reported that breast cancer cells treated with CBD have reduced levels of inflammatory cytokines, such as C-C motif chemokine 3 (CCL3), granulocyte-macrophage colony-stimulating factor GM-CSF (CSF2), and macrophage inflammatory protein 2 (MIP-2), as well as decreased recruitment of macrophages to the tumour microenvironment [136].